EI
EIF.F Eifelhöhen-Klinik AG
- Market cap
- EUR 10.7M
- P/E
- 3.5x
- P/B
- 0.72x
- ROE
- 17.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is EIF.F undervalued?
Graham numberEIF.F trades 66.5% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Eifelhöhen-Klinik AG fundamental analysis
No fundamental analysis for Eifelhöhen-Klinik AG yet.
Eifelhöhen-Klinik AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Eifelhöhen-Klinik AG
MedNation AG operates facilities for outpatient and inpatient orthopedics, geriatrics, and internal medicine in Germany. The company is also involved in specialist clinic for cardiological rehabilitation. In addition, it operates specialist clinic with indications for neurology and orthopedics, as well as medical care, nursing, and inpatient care facilities. The company was formerly known as Eifelhöhen-Klinik AG. MedNation AG was founded in 1970 and is based in Bonn, Germany.
Full company profileEifelhöhen-Klinik AG financial statements
Eifelhöhen-Klinik AG annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 47.8M | 46.9M | 49.3M | 48.5M | 35.5M | 35.8M | 37.5M | 45.3M | 48.8M | 52.8M |
| Gross Profit | 39.7M | 38.9M | 40.7M | 39.9M | 28.7M | 28.5M | 29.5M | 38.7M | 42.3M | 46.4M |
| Operating Income | 1.28M | 361K | 552K | 3.63M | -96.2K | -520K | -138K | 1.43M | 1.49M | 3.47M |
| EBITDA | - | 2.59M | 2.39M | 8.63M | 6.47M | 3.22M | 4.75M | 2.98M | 2.71M | 5.32M |
| Net Income | 4.51M | -114K | -1.11M | -773K | -1.42M | -4.40M | -1.89M | 481K | 84.4K | 2.51M |
| EPS | - | -0.04 | -0.37 | -0.26 | -0.47 | -1.46 | -0.63 | 0.16 | 0.03 | 0.89 |
| Balance Sheet | ||||||||||
| Total Assets | 57.8M | 60.6M | 55.9M | 76.4M | 70.3M | 79.3M | 75.4M | 37.9M | 36.2M | 37.7M |
| Total Liabilities | 39.1M | 42.9M | 39.6M | 59.7M | 55.4M | 68.5M | 65.6M | 25.2M | 23.6M | 22.4M |
| Shareholders' Equity | 18.2M | 17.2M | 15.7M | 16.0M | 14.3M | 10.0M | 9.20M | 11.8M | 11.6M | 14.1M |
| Cash & Short-term Investments | 16.1M | 13.7M | 5.58M | 2.88M | 3.66M | 3.49M | 5.13M | 4.19M | 2.97M | 3.57M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 1.19M | 2.23M | 311K | 3.00M | 4.76M | 3.63M | 607.00 | 991K | 2.31M | 2.21M |
| Capital Expenditure | 2.33M | 7.28M | 602K | 1.29M | 431K | 957K | 316.00 | 375K | 871K | 1.45M |
| Free Cash Flow | - | -5.28M | -365K | 1.70M | 4.30M | 2.67M | 291.00 | 616K | 1.44M | 767K |
| Ratios | ||||||||||
| ROE | 24.8% | -0.7% | -7.1% | -4.8% | -9.9% | -43.9% | -20.5% | 4.1% | 0.7% | 17.8% |
| ROA | 7.8% | -0.2% | -2.0% | -1.0% | -2.0% | -5.5% | -2.5% | 1.3% | 0.2% | 6.7% |
| Net Profit Margin | 9.4% | -0.2% | -2.3% | -1.6% | -4.0% | -12.3% | -5.0% | 1.1% | 0.2% | 4.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Eifelhöhen-Klinik AG dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jul 12, 2017
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | EUR 1.24M | 0.41 | - |
| 2016 | EUR 1.24M | - | 27.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 10:1 on Jan 29, 1999.
Who owns Eifelhöhen-Klinik AG
- Insiders 55.97%
- Institutions 3.47%
- Public & others 40.56%
- Shares outstanding 2.81M
- Free float 1.33M
Eifelhöhen-Klinik AG company profile
- Company name
- Eifelhöhen-Klinik AG
- Ticker
- EIF.F
- ISIN
- DE0005653604
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 850
- Fiscal year end
- December
- Address
- Graurheindorfer Str. 137, Bonn, Germany, 53117
- Phone
- 49 228 967782 0
- Website
- mednation.de
About Eifelhöhen-Klinik AG
MedNation AG operates facilities for outpatient and inpatient orthopedics, geriatrics, and internal medicine in Germany. The company is also involved in specialist clinic for cardiological rehabilitation. In addition, it operates specialist clinic with indications for neurology and orthopedics, as well as medical care, nursing, and inpatient care facilities. The company was formerly known as Eifelhöhen-Klinik AG. MedNation AG was founded in 1970 and is based in Bonn, Germany.
Eifelhöhen-Klinik AG management
1- Mr. Dirk IsenbergChairman of Management Board